Form 4: Walgreens Boots Alliance Sells Additional Cencora Shares
SEC Form 4 Filing
Walgreens Boots Alliance continues to reduce its stake in Cencora, selling shares through both open market and private transactions.
Summary
- Walgreens Boots Alliance, Inc. (WBA) has filed a Form 4 with the SEC indicating a change in beneficial ownership of Cencora, Inc. [COR] stock.
- The filing reports a transaction that occurred on August 1, 2024.
- WBA Holdings, an indirect wholly-owned subsidiary of Walgreens Boots Alliance, sold 4,438,171 shares of Cencora common stock.
- The sale was executed at a price of $240.56 per share.
- The sale included 3,398,929 shares sold pursuant to Rule 144 and 1,039,242 shares sold in a private transaction to Cencora.
- Following the transaction, Walgreens Boots Alliance beneficially owns 19,980,000 shares of Cencora indirectly through WBA Holdings.
Sentiment
Score: 5
Explanation: The document itself is neutral, simply reporting a transaction. The sentiment is neither particularly positive nor negative as it reflects a planned divestiture.
Future Outlook
The document does not contain specific forward-looking statements regarding Cencora's future performance or Walgreens Boots Alliance's future transactions.
Industry Context
Walgreens Boots Alliance's continued reduction of its stake in Cencora reflects a strategic shift in its investment portfolio. This is not uncommon for large corporations to divest holdings to focus on core business operations or to generate capital.
Stakeholder Impact
- The sale of shares could have a minor impact on Cencora's stock price in the short term.
- The transaction provides Walgreens Boots Alliance with additional capital, potentially benefiting its shareholders.
Key Dates
| Date | Description |
|---|---|
| March 18, 2013 | Date of the Framework Agreement among Walgreens, Alliance Boots GmbH, and Cencora. |
| April 15, 2014 | Date of initial Schedule 13D filing by Walgreen Co. |
| August 1, 2024 | Date of the reported transaction (sale of Cencora shares). |
| August 5, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.